Epigenetics refers to the covalent modification of DNA, RNA, or protein that result in changes to the function and/or regulation of these molecules, without altering their primary sequences. Epigenetics has its applications in large number of fields including oncology, drug discovery, disease diagnosis, developmental biology and plant sciences. It is one of the most widely used techniques for cancer biomarkers discovery and development. According to GLOBOCON, 2012 prevalence of cancer is growing. For instance, there were 14.1 million new cancer cases, 8.2 million cancer deaths, and 32.6 million people living with cancer (within five years of diagnosis) in 2012 globally. A high prevalence of cancer will majorly drive the epigenetics market. Furthermore, factors such as an increasing research activities and R&D funding by private and government organizations will also aid to the growth of this market.
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=896